Literature DB >> 19139425

Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma.

Joel E Tepper, Bert O'Neil.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19139425     DOI： 10.1200/JCO.2008.19.5982

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection.

Authors:  Guodong Wang; Aiwen Wu; Xiaojing Cheng; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

Review 2.  Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.

Authors:  Pierfrancesco Franco; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Elisabetta Trino; Stefania Martini; Giuseppe Carlo Iorio; Maria Antonietta Satolli; Mario Airoldi; Renato Romagnoli; Michele Camandona; Umberto Ricardi
Journal:  Med Oncol       Date:  2017-02-07       Impact factor: 3.064

Review 3.  Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.

Authors:  Gillian H Bain; Russell D Petty
Journal:  Oncologist       Date:  2010-03-04

4.  Locally advanced cancer of the esophagus, current treatment strategies, and future directions.

Authors:  Osama E Rahma; Tim F Greten; Austin Duffy
Journal:  Front Oncol       Date:  2012-05-24       Impact factor: 6.244

5.  An Unusual Course of Metastatic Gastroesophageal Cancer.

Authors:  William H Smith; Sofya Pintova; Christopher J DiMaio; Panagiotis Manolas; Dong-Seok Lee; Spiros P Hiotis; Maria Kartsonis; Randall F Holcombe; Kavita V Dharmarajan
Journal:  Case Rep Oncol Med       Date:  2015-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.